SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-23-028417
Filing Date
2023-02-08
Accepted
2023-02-08 16:15:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d292424dsc13ga.htm SC 13G/A 37197
  Complete submission text file 0001193125-23-028417.txt   38696
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics, Inc. (Subject) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91921 | Film No.: 23599283
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O 4D MOLECULAR THERAPEUTICS INC. 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address
Kirn David (Filed by) CIK: 0001834021 (see all company filings)

Type: SC 13G/A